A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
10/1998
10/21/1998	EP0871725A2 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods
10/21/1998	EP0871720A2 Beta-secretase, antibodies to beta-secretase, and assays for detecting beta-secretase inhibition
10/21/1998	EP0871704A1 Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor
10/21/1998	EP0871673A1 Bispecific antibodies in which the binding capability is reversibly inhibited by a photocleavable moiety
10/21/1998	EP0871667A1 G-protein coupled receptor
10/21/1998	EP0871663A2 New form of amphiregulin, methods for producing and using the same and compositions comprising the same
10/21/1998	EP0871641A1 Multiple administrations of anti-tnf antibody
10/21/1998	EP0871495A1 Redirection of cellular immunity by receptor chimeras
10/21/1998	EP0871492A2 Mesothelium antigen and methods and kits for targeting it
10/21/1998	EP0871490A1 Branched hydrazone linkers
10/21/1998	EP0871487A1 Dendritic cell stimulatory factor
10/21/1998	EP0871486A1 Diphtheria toxin epitopes
10/21/1998	EP0871485A1 COMPOSITIONS AND METHODS FOR CATALYZING HYDROLYSIS OF HIV gp120
10/21/1998	EP0871482A1 Recombinant vesiculoviruses and their uses
10/21/1998	EP0871481A1 Pseudomonas exotoxin as immunogenic carrier in synthetic conjugate vaccines
10/21/1998	EP0871480A1 T cells mediating an immune response and methods of use
10/21/1998	EP0871479A2 Oral administration of pneumococcal antigens
10/21/1998	EP0871478A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation
10/21/1998	EP0871477A1 Method for obtaining receptor agonist antibodies
10/21/1998	EP0871455A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
10/21/1998	EP0705277B1 Prostaglandin receptor ep3 and dna encoding it
10/21/1998	EP0651740B1 Amino acid linked nitrogen mustard derivatives and their use as prodrugs in the treatment of tumours
10/21/1998	EP0643719B1 Nucleic acid sequences coding for or complementary to nucleic acid sequences coding for interleukin 9 receptor
10/21/1998	EP0586438B1 Hepatitis a virus production
10/21/1998	CN1196390A Chicken Marek's disease virus genic mutant strain and its application
10/20/1998	US5824839 Delivery of gene products via mesangial cells
10/20/1998	US5824805 Branched hydrazone linkers
10/20/1998	US5824791 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
10/20/1998	US5824788 Cloning of gene encoding the GP28.5 protein of toxoplasma gondii; peptide fragments of said protein and their applications
10/20/1998	US5824782 Immunoconjugates II
10/20/1998	US5824781 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
10/20/1998	US5824777 Isolated amino acid sequences of the complete cdna sequence coded by the rna genome of the aik-c strain
10/20/1998	US5824776 Cell-targeted lytic pore-forming agents
10/20/1998	US5824656 Immunizing poultry
10/20/1998	US5824655 Anti-transforming growth factor-β gene therapy
10/20/1998	US5824649 Diagnosis, vaccines
10/20/1998	US5824640 Substances of polypeptide nature useful in human therapy
10/20/1998	US5824538 Shigella vector for delivering DNA to a mammalian cell
10/20/1998	US5824537 Processes for the in vitro culture, attenuation of the virulence and cloning of parasites of the genus babesia and their applications
10/20/1998	US5824536 Influenza virus replicated in mammalian cell culture and vaccine production
10/20/1998	US5824525 Construction of Pasteurella haemolytica vaccines
10/20/1998	US5824514 Process for obtaining dna, rna, peptides, polypeptides, or proteins, through use of transformed host cells containing genes capable of expressing these products
10/20/1998	US5824508 Dna and amino acid sequences, vectors and host cells
10/20/1998	US5824504 Polynucleotides
10/20/1998	US5824500 Nucleic acid encoding novel human KDEL receptor
10/20/1998	US5824492 Polypeptides having kinase activity, their preparation and use
10/20/1998	US5824490 Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein
10/20/1998	US5824482 Detection of antibodies for lav virus and antigens doe diagnosis with peptides
10/20/1998	US5824466 Can be used for in vitro detection of skin disorders, cancers
10/20/1998	US5824322 Compositions and methods for growth promotion
10/20/1998	US5824321 Polypeptides and proteins for immunology in vaccines
10/20/1998	US5824319 Vaccine for immunization against chicken pox and shingles
10/20/1998	US5824318 Avirulent herpetic viruses useful as tumoricidal agents and vaccines
10/20/1998	US5824316 Deleting the nucleic acid sequence encoding the leader (l) proteinase from an infectious cdna copy of the viral genome
10/20/1998	US5824315 And complexs between them; attaching n-terminus of the peptide epitope a hydrophobic amino acid or peptide containing it; treatment of autoimmune diseases
10/20/1998	US5824313 Administering specific antigen and lymphoid organ modifying agent selected from calcipotriene and 1,25-dihydroxy-16-ene vitamin d3; immune resonse against hepatitis, flu, diphtheria, tetanus, pertussis, measles, mumps, rubella, polio, pneumonia,
10/20/1998	US5824310 Lipopplysaccharide conjugate vaccines
10/20/1998	US5824309 Peptides inserted into the frame of structural protein
10/20/1998	US5824307 Human-murine chimeric antibodies against respiratory syncytial virus
10/20/1998	US5824306 Dirofilaria and brugia ankyrin proteins, nucleic acid molecules, and uses thereof
10/20/1998	US5824304 Peripheralization of hematopoietic stem cells
10/20/1998	US5824303 Dna sequence encoding, proteins and peptides
10/20/1998	US5824299 Administering an ip-10 polypeptide to decrease non-neoplastic endothelial cell proliferation; treating hemangioma, keloids, proliferative retinal disorder, inflammation, fibrosis
10/20/1998	US5824292 Colloidal zinc oxide antiplaque agents coated with carbohydride or peptide recognized by bacterial adhesion
10/20/1998	US5824084 Method of preparing a composite bone graft
10/20/1998	CA1340097C Synthetic antigen for detection of aids-related disease
10/15/1998	WO1998045444A1 Vaccines with enhanced intracellular processing
10/15/1998	WO1998045441A1 Human gtp binding protein
10/15/1998	WO1998045432A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	WO1998045420A1 Pca3, pca3 genes, and methods of use
10/15/1998	WO1998045415A1 Method for inactivating a virus
10/15/1998	WO1998045408A2 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/15/1998	WO1998045332A2 Humanized antibodies and methods for forming humanized antibodies
10/15/1998	WO1998045331A2 Anti-vegf antibodies
10/15/1998	WO1998045328A2 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	WO1998045325A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	WO1998045324A1 Use of cholera toxin mutants as mucosal adjuvants
10/15/1998	WO1998045323A1 Synthetic peptides useful in biological assays for detecting infections caused by group o hiv-1 viruses
10/15/1998	WO1998045318A1 Activated peptides and conjugates
10/15/1998	WO1998045312A1 Serogroup-specific nucleotide sequences in the molecular typing of bacterial isolates and the preparation of vaccines thereto
10/15/1998	WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998	WO1998044948A2 Intravenous immune globulin formulation containing a non-ionic surface active agent with improved pharmacokinetic properties
10/15/1998	WO1998044947A1 Allergen formulation
10/15/1998	WO1998044946A1 Viral obesity methods and compositions
10/15/1998	WO1998044945A1 Non-infectious, protease defective hiv particles and nucleic acid molecules encoding therefor
10/15/1998	WO1998044944A2 Stabilized human papillomavirus formulations
10/15/1998	WO1998044943A1 Leishmania vaccine
10/15/1998	WO1998044939A1 Anti-peptide antibody against human cytochrome p450 3a4
10/15/1998	WO1998044788A2 Animal model for evaluation of vaccines
10/15/1998	WO1998029134A3 Microporation of tissue for delivery of bioactive agents
10/15/1998	WO1998024887A3 Parasitic nematode transglutaminase proteins, nucleic acid molecules, and uses thereof
10/15/1998	WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998	DE19714875A1 First aid kit for prophylaxis of blood-borne infections e.g. HIV or hepatitis in e.g. police and medical or laboratory staff
10/15/1998	CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998	CA2286690A1 Method for inactivating a virus
10/15/1998	CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998	CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998	CA2286294A1 Stabilized human papillomavirus formulations
10/15/1998	CA2286283A1 Human gtp binding protein
10/15/1998	CA2286008A1 Anti-peptide antibody against human cytochrome p450 3a4

1 ... 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 1574 1575 1576 1577 1578 1579 1580 1581 ... 1823